• Beautiful Skin the Smart Way!
Home
 

Zolinza Approved by FDA to Treat CTCL

0

In early October, 2006, the drug Zolinza was approved by the FDA to treat CTCL (cutaneous T-cell lymphoma), a rare form of skin cancer.

Zolinza is permitted for use if the disease gets worse, persists, or recurs after treatment with other skin cancer medications. CTCL impacts about 3 in 1 million Americans per year, and was thus approved under the FDA’s Orphan Drug Program, which offer companies incentives for treating diseases which affect fewer than 200,000 Americans each year.

Zolinza is manufactured by Pantheon, Inc., for the drug giant Merck & Co.

The drug is not recommended for pregnant women, as animal studies indicate it could cause fetal harm.

Tags: ctcl, cutaneous-T-cell-lymphoma, FDA, merck, skin-cancer, zolinza

Filed under The Latest Skin Care News by ... #

Leave a Comment

Click here to cancel reply.

You must be logged in to comment

RSS Healthy Habits

  • Soap and Water Best Defense Against MRSA
  • Caucasian Women More Likely to Lose Weight In Groups
  • Exercise Even 10 Minutes A Day

Archives

  • November 2008
  • February 2008
  • January 2008
  • November 2007
  • October 2007
  • September 2007
  • August 2007
  • July 2007
  • June 2007
  • May 2007
  • April 2007
  • March 2007
  • February 2007
  • January 2007
  • December 2006
  • November 2006
  • October 2006
  • September 2006
  • August 2006
  • July 2006
  • June 2006

Grab Our Feed!

Enter your email address:

Delivered by FeedBurner

Categories

  • General Skin Care Information
  • The Latest Skin Care News

2. Our Sister Sites

  • Beautiful Summer Skin
  • Healthy Habits for Healthy Skin
  • Skin Care for All Skin Types
  • Skin Care Product Reviews
  • SkinCareSmarts Store
  • Solve Your Skin Problems
  • What Skin Treatment is Right for You?
Made with Semiologic Pro • Boxed, Blue skin by Denis de Bernardy